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Intra-macrophage bacterial infections cause significant morbidity and mortality in both the
developed and developing world. Protective host immune responses to these infections
initially requires the activation and expansion of pathogen-specific CD4Th1 cells within lym-
phoid tissues and subsequent relocation of these effector cells to sites of infection. After
entering infected tissues, the elicitation ofTh1 bactericidal activity can be triggered by cog-
nate or non-cognate signals that are delivered by locally infected antigen-presenting cells
and innate cells. However, the contribution of non-cognate stimulation to the resolution of
bacterial infection remains poorly understood, especially in the context of a Th1 response.
Here, we review the current data on Th1 cell activation and expansion in mouse models
of Salmonella and Chlamydia infection and discuss the potential role of non-cognate Th1
cell stimulation in these disease models. Greater understanding of this pathway of T cell
activation may lead to the design of therapeutics or vaccines to combat intra-macrophage
pathogens.
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INTRODUCTION
The mammalian immune system contains a variety of cell types
that respond in a highly coordinated fashion to eradicate microbial
pathogens. The different cell populations that mediate this host
defense capability are conveniently assigned to innate or adaptive
immune compartments depending a variety of factors, including
the tempo of the effector function produced, the use of certain
pathogen recognition receptors, and whether these cells have an
inherent capacity to confer immune memory. Innate immune
responses typically invoke an immediate effector response, make
use of germ-line encoded receptors with a restricted capacity for
pathogen recognition, and lack the ability to confer a stronger
response to secondary infection (1). In contrast, adaptive immune
responses require a period of maturation before effector functions
are elaborated, utilize complex, rearranged receptors that allow a
wider range of specificities, and confer a modified host response to
re-infection (2). This general compartmentalization of cells into
innate and adaptive arms of the immune system is useful since
it provides a conceptual framework that reduces complexity in
understanding the dynamics of host–pathogen interactions. How-
ever, as might be expected, this model is an oversimplification and
some cells of the innate immune system can display characteristics
of the adaptive response, and vice versa (3–6). In this review, we
will discuss the capacity of adaptive Th1 cells to elaborate effector
functions in response to innate stimuli and thus under these con-
ditions appear to function as a component of the innate immune
response. The ability of these expanded effector lymphocytes to
blur the lines between innate and adaptive immunity may be a crit-
ical component of protective immunity to Salmonella, Chlamydia,
and other intracellular bacteria.
GLOBAL IMPACT OF SALMONELLA AND CHLAMYDIA
INFECTIONS
Salmonella can cause different clinical diseases in a human host,
depending upon the genome of the infecting Salmonella serovar
and the immune competence of the infected host (7, 8). Typhoid
fever is caused by human transmission of Salmonella enterica
serovar Typhi or serovar Paratyphi and this disease remains preva-
lent in parts of Africa and Asia (9). Current estimates suggest
that typhoid causes 217,000 deaths globally every year, the impact
of which is felt predominantly in geographical regions with lim-
ited access to clean water or basic sanitation infrastructure (10).
Although typhoidal serovars enter the human host via the intes-
tine, much of the in vivo bacterial replication occurs in the sys-
temic tissues of the liver, spleen, and bone marrow. In contrast,
many other Salmonella serovars can cause local gastro-intestinal
infections that are often self-limiting but are a major cause of food-
borne infection in the US and other developed nations (11, 12).
Thus, Salmonella infection has a global footprint and largely affects
developed and developing nations with different patterns of sys-
temic or localized disease. A third disease caused by Salmonella has
emerged in sub-Saharan Africa and primarily affects patients with
an immature or compromised immune system, either due to age,
co-infection, or nutritional status (13, 14). These Salmonella infec-
tions can be systemic and are caused by non-typhoidal serovars
and therefore this disease is collectively referred to as invasive
non-typhoidal Salmonellosis (NTS). While vaccines are currently
available for typhoid, these are not widely used in typhoid endemic
areas due to concerns about efficacy, safety, or cost (8). The
development of improved vaccines for typhoid and NTS there-
fore remains a priority. Greater understanding of host protective
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immune mechanisms during Salmonella infection will be required
in order to meet this important goal.
While Salmonella is a facultative intracellular pathogen that can
grow inside and outside host cells, Chlamydia is an obligate intra-
cellular organism and is only metabolically active within host cells
(15). Chlamydia trachomatis causes a sexually transmitted infec-
tion in humans that is now the most common notifiable disease in
the US (16). The 1.4 million Chlamydia cases reported in 2011 rep-
resent an 8% increase over 2010 and is the largest number of cases
ever reported to the Centers for Disease Control (CDC) for any sin-
gle condition (16). Overall, the CDC reports an 8.3% positivity rate
among young women screened at family planning clinics, making
Chlamydia one of the most prevalent bacterial infections in the
US (17). Although most Chlamydia infections are initially asymp-
tomatic, they cause serious pelvic inflammatory disease (PID) in
5–15% of untreated female patients (18, 19). Approximately one
in six women who develop PID become infertile, while many oth-
ers develop chronic pelvic pain, ectopic pregnancy, and if exposed
to HIV, Chlamydia-infected women are five times more likely to
acquire the virus (18–20). Thus, Chlamydia infection represents a
growing healthcare problem in the US and greater understanding
of protective immunity in the female reproductive tract will be
required to develop an effective vaccine.
ROLE OF CD4 Th1 CELLS IN PROTECTIVE IMMUNITY TO
SALMONELLA AND CHLAMYDIA
Given the location of Chlamydia infection in the reproductive tract
and Salmonella infection in the intestine, the immune response to
these infections will undoubtedly contain unique tissue-specific
components. However, in both mouse models of Salmonella and
Chlamydia infection, pathogen-specific CD4 Th1 cells have been
found to be essential for successful resolution of primary infec-
tion (21, 22). In the Salmonella model, oral infection of C57BL/6
mice with attenuated bacteria generates a systemic infection that
eventually resolves over a period of several weeks (23). The ability
to resolve this infection is absent in mice lacking MHC class-II-
restricted T cells, IFN-γ, or the Th1 transcription factor T-bet (24,
25). Furthermore, successful resolution of Salmonella infection
correlates with the expansion of Salmonella-specific Th1 cells in
systemic tissues (23, 26).
Genital inoculation of C57BL/6 mice with Chlamydia muri-
darum generates a self-limiting ascending infection of the upper
reproductive tract (21). Similar to Salmonella infection, the reso-
lution of primary C. muridarum infection requires the presence of
MHC class-II restricted T cells and IFN-γ (27). The Chlamydia-
specific T cell response has been visualized using antigen-specific
reagents and the predominant T helper subset detected in drain-
ing lymph nodes and spleen consists of a Th1 population that
expresses T-bet and secretes IFN-γ (28, 29). In both infection
models, the contribution of CD8 T cells and B cells in resolving
primary infection is thought to be limited (27, 30–33), although
recent data suggest a requirement for B cells in preventing bacter-
ial dissemination to systemic tissues following Chlamydia genital
challenge (28). It is not yet clear whether this implies a require-
ment for B cells in antigen presentation to CD4 T cells or simply a
requirement for early antibody production.
Secondary responses to Salmonella and Chlamydia infection
have also been examined and the data suggest a wider range of
lymphocyte responses that can contribute to bacterial clearance
(21, 34). Despite the fact that Salmonella and Chlamydia replicate
intracellularly in an infected host, B cells and antibody can con-
tribute to the resolution of secondary infection (30–32, 35, 36).
A role for B cells is evident in experiments examining acquired
immunity in B cell-deficient mice or by examining the protec-
tive immunity mediated by the transfer of immune serum (31, 32,
36–38). Similarly, CD8 T cells have been reported to contribute
to secondary protection against both Salmonella and Chlamydia
(24, 27, 39), although a recent report examining Salmonella infec-
tion of MHC class-I, perforin-, and granzyme-deficient mice did
not detect an impaired protective response to secondary infec-
tion (33). Despite the expanded contribution of antibody and
CD8 T cells in secondary protective immunity, CD4 Th1 cells
are still thought to be the primary cell type involved in the res-
olution of secondary infection (21, 22). Thus, the development
of pathogen-specific CD4 Th1 cells is essential for the develop-
ment of protective immunity in mouse models of Salmonella and
Chlamydia infection.
COGNATE SIGNALS DRIVING T CELL ACTIVATION AND
REACTIVATION
Naïve pathogen-specific CD4 T cells are activated in secondary
lymphoid tissues by dendritic cells expressing CD80/86 and dis-
playing microbial peptides on surface MHC class-II (40). In both
Salmonella and Chlamydia infection models, TCR transgenic mice
and MHC class-II tetramers have been used to visualize naïve T
cell activation, expansion, and acquisition of effector functions
in vivo (28, 41–43). Initial T cell expansion occurs in the Peyer’s
patch and mesenteric lymph nodes after oral infection with Sal-
monella (41, 44). However, systemic expansion of CD4 T cells
can also occur in the spleen and recent evidence suggests that
these mucosal and systemic responses are functionally and anti-
genically distinct (43). Thus, while flagellin-specific CD4 Th17
cells expand in the intestine of Salmonella-infected mice, CD4
Th1 cells specific for components of the Salmonella Pathogenic-
ity Island 2 (SPI2) Type III Secretion System were expanded in
the spleen (43). Genital infection of mice with C. muridarum
initially drives Chlamydia-specific T cell expansion in the drain-
ing ileac lymph, before systemic expansion occurs in the spleen
(28). Unlike Salmonella infection, the antigenic targets of the CD4
response appear to be similar in mucosal and systemic locations
and Th1 cells were primarily detected both locally and system-
ically. The most prominent feature of the immune response in
both Salmonella and Chlamydia infection models is that a large
pool of expanded pathogen-specific Th1 cells is generated. The
activation and clonal expansion of Salmonella-specific T cells is
strictly dependent on cognate stimulation since flagellin-specific
T cells remain unactivated after infection of mice with flagellin-
deficient Salmonella (41, 44). Thus, Th1 cells arise from a relatively
infrequent pool of naïve pathogen-specific T cells in response to
cognate (TCR-dependent) signals that are delivered in lymphoid
tissues and these signals eventually lead to clonal expansion and
effector development.
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NON-COGNATE ACTIVATION OF EFFECTOR T CELLS
When Th1 cells relocate to an infected non-lymphoid tissue, they
can produce IFN-γ locally in order to restrain intracellular bacter-
ial replication (45). The stimulatory signals required to elicit local
IFN-γ from effector T cells in tissues could potentially involve
cognate stimulation via peptide/MHC complexes on the surface
of infected cells or resident dendritic cells (Figure 1). However,
many intracellular pathogens have evolved strategies that pre-
vent MHC presentation of microbial peptides or down-regulate
surface MHC expression on infected cells (46, 47). While down-
regulation of MHC class-I is often discussed as a viral evasion
strategy (48), Salmonella have also been reported to reduce expres-
sion of MHC class-II of antigen-presenting cells (49). Thus, in
the absence of cognate ligands, Th1 cells may simply recognize
inflammatory cues such as cytokines and TLR ligands in infected
tissues to secrete IFN-γ (Figure 1). However, the relative contri-
bution of cognate versus non-cognate signals in the eradication of
intracellular pathogens is not fully understood.
Effector CD4 T cells that have relocated to non-lymphoid
tissues retain the ability to respond to cognate signals in that
location. Indeed, in a non-infectious model system, antibody
that effectively blocked the peptide/MHC complex reduced the
ability of CD4 T cells to produce effector cytokines (50). Simi-
larly, recent experiments with bone marrow chimeras containing
MHC class-II-deficient and MHC class-II sufficient myeloid cells
demonstrated an increased burden of M. tuberculosis in host cells
lacking MHC class-II (51). These data support the idea that Th1
cells scan infected tissues and can respond to local cognate signals
to produce cytokines. However, the ability to respond to cognate
signals may not always be required for the elaboration of effector
functions. Studies of CD8 T cell effector function have demon-
strated that expanded pathogen-specific T cells can secrete IFN-γ
in response to a variety of inflammatory cytokines including IL-
12, IL-18, and IL-15 (52–54). In a similar manner, CD4 cells have
been shown to produce cytokines after direct ligation of surface
TLRs by microbial products (3). Thus, non-cognate stimulation
of Th1 cells could potentially be a major contributing factor to
bacterial clearance from tissues during intracellular infections.
In a mouse model of Salmonella infection, a large proportion
of CD4 T cells can be rapidly induced to secrete IFN-γ following
intravenous injection of heat-killed bacteria (23). It was initially
assumed that this complex mixture of bacterial antigens was able to
efficiently activate Salmonella-specific Th1 cells via cognate signals
delivered after antigen presentation of heat-killed bacteria. How-
ever, it was subsequently demonstrated that this large response
from Th1 cells could also be induced following the injection of
TLR ligands and more importantly also occurred in the absence
of host MHC class-II (55, 56). Recently, this response was shown
to be due to the induction of IL-18 and IL-33 in response to both
TLR and inflammasome stimulation (57). The primary inflamma-
some components involved in recognition of Salmonella infection
are NLRC4 and NLRP3 (58). Although NLRC4 can be activated
in response to flagellin, bacteria that lacked flagellin expression
were still able to induce non-cognate T cell activation suggesting
that other components also participate in this response. Overall,
these data suggest that inflammasome activation combines with
FIGURE 1 |Th1 cells can be activated by cognate and non-cognate
stimuli in infected tissue. Naïve CD4 T cells are activated in lymphoid
tissues to generate Th1 cells specific for Salmonella. These
Salmonella-specific T cells can enter infected tissue and be stimulated by
cognate (MHC/peptide) stimuli (TOP) or non-cognate (IL-18) stimuli. In both
cases, the result of this stimulation is the production of IFN-gamma and
resolution of the infection.
TLR ligation to induce IL-18 and IL-33 production and that these
cytokines drive T cell stimulation. Indeed, optimal IFN-γ produc-
tion required T cell expression of IL-18R and IL-33R and mice
containing a T cell-specific deficiency in Myd88 were less able to
control the growth of Salmonella (57). A very similar pathway
of non-cognate T cell activation has been reported following the
injection of bacterial flagellin, although activation of CD8 T cells
in this case was thought to require direct flagellin recognition by
NLRC4 expressed by dendritic cells (59). Together, these data sug-
gest that, during Salmonella infection, non-cognate signals may
be vitally important for driving CD4 Th1 and CD8 T cells to
produce IFN-γ and that mice lacking these particular pathways
may be unable to generate an effective adaptive response. Inter-
estingly, a similar non-cognate response was detected from Th1
cells in Chlamydia-infected mice (57), suggesting that non-cognate
activation of CD4 T cells may be a common feature of the host
immunity to intracellular bacteria. Future experiments examining
other intracellular pathogens will be important to determine how
ubiquitous this pathway is for eliciting protective Th1 responses
to microbial pathogens. However, the finding that clearance of M.
tuberculosis from individual myeloid cells requires direct cognate
stimulation implies that an appropriate balance of cognate and
non-cognate signals in infected tissues will be important for Th1
responses to different intracellular pathogens (51). Indeed, it is
possible that cognate and non-cognate signals are each respon-
sible for Th1 cytokine production at different stages of the host
response, in different anatomical locations, or simply depending
on the overall bacterial load within an infected tissue.
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CONTRIBUTION OF NON-COGNATE T CELL ACTIVATION TO
PATHOGEN CLEARANCE
The non-cognate elicitation of an effector response from expanded
T cells may be required to specifically deal with pathogens that are
able to alter host MHC expression or affect the presentation of
microbial peptides in infected tissues. Any Th1 cell that enters
an infected tissue would therefore retain some capacity to pro-
duce IFN-γ in response to local inflammation. Indeed, it has been
shown that IFN-γ produced locally can induce iNOS expression
from locally infected macrophages, even an individual macrophage
happens to lack expression of MHC class-II (45). Thus, there is
a degree of non-specificity in the function of Th1 cells within
infected tissues. The ability of these same T cells to respond to
non-cognate signals may simply further decrease the activation
threshold for eliciting bactericidal response. Although it has not
been directly examined in vivo, the contribution of non-cognate
Th1 cell stimulation may be directly related to the overall pathogen
burden in the infected tissue. Thus, if the overall tissue burden is
low, then PAMP-elicited cytokines such as IL-18 and IL-33 would
also be expected to be at low concentrations, leaving Th1 cells to
seek out cognate stimulation and thus constraining T cell activa-
tion to a very localized radius around the few infected cells in the
tissue. In contrast, if a Th1 cell encounters high concentrations
of inflammatory cytokines, the threshold for T cell stimulation
would effectively be lowered, allowing immediate and widespread
production of IFN-γ. Such a lower threshold of activation may
be particularly important when an infected host is combating a
rapidly dividing or rapidly spreading pathogen such as Salmo-
nella, but conversely may be less important for immunity to a slow
growing pathogen such as M. tuberculosis.
Another potential role for non-cognate T cell activation could
occur in situations of bacterial co-infection. Indeed, a role for non-
cognate T cell activation in driving pathology has been examined
in the context of influenza and bacterial co-infections (60). In
this case, an expanded pool of virus-specific CD8 T cells could
be rapidly activated to produce harmful pathology in response
to inflammatory cytokines elicited by bacterial infection. Con-
versely, persistent viral stimulation of macrophages can sometimes
provide protection against some intracellular bacterial infections
(61). In the case of Th1 cells, a pathway of non-cognate activa-
tion could be a primary driver of protective immunity during
a co-infection. For example, if an individual is infected with an
intracellular pathogen and therefore has invested in the expansion
and functional maturation of a pool of Th1 cells, the simultaneous
encounter with an unrelated secondary infection may well recruit
and activate these Th1 cells in a non-cognate manner. Indeed,
the original discovery of macrophage activation was surprising
because the efferent phase of the adaptive response involved a
relatively non-specific mechanism and was demonstrated using
a co-infection model where Brucella infection prevented pro-
ductive infection with Listeria. However, a role for non-cognate
T cell activation in the elicitation of protective immunity dur-
ing co-infections has not yet been described. Overall, it seems
most likely that non-cognate mechanisms of Th1 cell activation
could have evolved to help the host combat bacterial evasions of
host immunity, superior bacterial cell division, or co-infections.
Future research in this area is required to examine each of these
possibilities.
CONCLUSION
Naïve CD4 T cells are activated by cognate signals leading to the
expansion of an effector pool of pathogen-specific T cells that can
migrate to infected tissues and deliver local anti-microbial effects.
Recent data have demonstrated that Th1 cells can be activated
within infected tissues in response to cognate and/or non-cognate
signals that arise from TLR and inflammasome activation. Thus,
although the adaptive response is regulated by highly specific
antigen-specific surface receptors, an expanded pool of effector
cells retains the ability to respond immediately to inflammatory
cues that are normally associated with the innate arm of the
immune system. This functional capability reinforces our grow-
ing understanding that innate and adaptive immune systems are
not completely separate entities but instead work in a coordinated
fashion to resolve infection with microbial pathogens. This ability
of expanded effector lymphocytes to blur the lines between innate
and adaptive immunity may be a critical component of protec-
tive immunity to Salmonella, Chlamydia, and other intracellular
bacteria.
ACKNOWLEDGMENTS
This work was supported by grants from the National Insti-
tutes of Health to Stephen J. McSorley (AI055743, AI076278, and
AI056172).
REFERENCES
1. Broz P, Ohlson MB, Monack DM. Innate immune response to Salmonella
typhimurium, a model enteric pathogen. Gut Microbes (2012) 3:62–70. doi:10.
4161/gmic.19141
2. Masopust D, Schenkel JM. The integration of T cell migration, differentiation
and function. Nat Rev Immunol (2013) 13:309–20. doi:10.1038/nri3442
3. Reynolds JM, Dong C. Toll-like receptor regulation of effector T lymphocyte
function. Trends Immunol (2013) 34:511–9. doi:10.1016/j.it.2013.06.003
4. Dostert C, Ludigs K, Guarda G. Innate and adaptive effects of inflammasomes
on T cell responses. Curr Opin Immunol (2013) 25:359–65. doi:10.1016/j.coi.
2013.02.008
5. Quintin J, Cheng SC, van der Meer JW, Netea MG. Innate immune memory:
towards a better understanding of host defense mechanisms. Curr Opin Immunol
(2014) 29C:1–7. doi:10.1016/j.coi.2014.02.006
6. Sheridan BS, Romagnoli PA, Pham QM, Fu HH, Alonzo F III, Schubert WD,
et al. Gammadelta T cells exhibit multifunctional and protective memory
in intestinal tissues. Immunity (2013) 39:184–95. doi:10.1016/j.immuni.2013.
06.015
7. Dougan G, John V, Palmer S, Mastroeni P. Immunity to salmonellosis. Immunol
Rev (2011) 240:196–210. doi:10.1111/j.1600-065X.2010.00999.x
8. McGregor AC, Waddington CS, Pollard AJ. Prospects for prevention of Salmo-
nella infection in children through vaccination. Curr Opin Infect Dis (2013)
26:254–62. doi:10.1097/QCO.0b013e32835fb829
9. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. Typhoid fever. N Engl J Med
(2002) 347:1770–82. doi:10.1056/NEJMra020201
10. Crump JA, Mintz ED. Global trends in typhoid and paratyphoid fever. Clin Infect
Dis (2010) 50:241–6. doi:10.1086/649541
11. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, et al. Food-
related illness and death in the United States. Emerg Infect Dis (1999) 5:607–25.
doi:10.3201/eid0506.990625
12. Costa LF, Paixao TA, Tsolis RM, Baumler AJ, Santos RL. Salmonellosis in cat-
tle: advantages of being an experimental model. Res Vet Sci (2012) 93:1–6.
doi:10.1016/j.rvsc.2012.03.002
13. Gordon MA. Salmonella infections in immunocompromised adults. J Infect
(2008) 56:413–22. doi:10.1016/j.jinf.2008.03.012
14. Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA.
Invasive non-typhoidal Salmonella disease: an emerging and neglected tropi-
cal disease in Africa. Lancet (2012) 379:2489–99. doi:10.1016/S0140-6736(11)
61752-2
Frontiers in Immunology | Immunological Memory July 2014 | Volume 5 | Article 319 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
McSorley Immune response to intracellular bacterial infections
15. Brunham RC, Rey-Ladino J. Immunology of Chlamydia infection: implica-
tions for a Chlamydia trachomatis vaccine. Nat Rev Immunol (2005) 5:149–61.
doi:10.1038/nri1551
16. Centers for Disease Control and Prevention. Sexually Transmitted Disease
Surveillance, 2008. Atlanta, GA: Department of Health and Human Services
(2009).
17. Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, et al.
Prevalence of chlamydial and gonococcal infections among young adults in the
United States. JAMA (2004) 291:2229–36. doi:10.1001/jama.291.18.2229
18. Gottlieb SL, Brunham RC, Byrne GI, Martin DH, Xu F, Berman SM. Intro-
duction: the natural history and immunobiology of Chlamydia trachomatis
genital infection and implications for Chlamydia control. J Infect Dis (2010)
201(Suppl 2):S85–7. doi:10.1086/652401
19. Gottlieb SL, Martin DH, Xu F, Byrne GI, Brunham RC. Summary: the natural
history and immunobiology of Chlamydia trachomatis genital infection and
implications for Chlamydia control. J Infect Dis (2010) 201(Suppl 2):S190–204.
doi:10.1086/652401
20. Fleming DT, Wasserheit JN. From epidemiological synergy to public health
policy and practice: the contribution of other sexually transmitted diseases
to sexual transmission of HIV infection. Sex Transm Infect (1999) 75:3–17.
doi:10.1136/sti.75.1.3
21. Farris CM, Morrison RP. Vaccination against Chlamydia genital infection uti-
lizing the murine C. muridarum model. Infect Immun (2011) 79:986–96.
doi:10.1128/IAI.00881-10
22. Griffin AJ, McSorley SJ. Development of protective immunity to Salmonella, a
mucosal pathogen with a systemic agenda. Mucosal Immunol (2011) 4:371–82.
doi:10.1038/mi.2011.2
23. Srinivasan A, Foley J, McSorley SJ. Massive number of antigen-specific CD4 T
cells during vaccination with live attenuated Salmonella causes interclonal com-
petition. J Immunol (2004) 172:6884–93. doi:10.4049/jimmunol.172.11.6884
24. Hess J, Ladel C, Miko D, Kaufmann SH. Salmonella typhimurium aroA-infection
in gene-targeted immunodeficient mice: major role of CD4+ TCR-alpha beta
cells and IFN-gamma in bacterial clearance independent of intracellular loca-
tion. J Immunol (1996) 156:3321–6.
25. Ravindran R, Foley J, Stoklasek T, Glimcher LH, McSorley SJ. Expression of T-
bet by CD4 T cells is essential for resistance to Salmonella infection. J Immunol
(2005) 175:4603–10. doi:10.4049/jimmunol.175.7.4603
26. Griffin AJ, McSorley SJ. Generation of Salmonella-specific Th1 cells requires sus-
tained antigen stimulation. Vaccine (2011) 29:2697–704. doi:10.1016/j.vaccine.
2011.01.078
27. Morrison RP, Feilzer K, Tumas DB. Gene knockout mice establish a primary pro-
tective role for major histocompatibility complex class II-restricted responses in
Chlamydia trachomatis genital tract infection. Infect Immun (1995) 63:4661–8.
28. Li LX, McSorley SJ. B cells enhance antigen-specific CD4 T cell priming and
prevent bacteria dissemination following Chlamydia muridarum genital tract
infection. PLoS Pathog (2013) 9:e1003707. doi:10.1371/journal.ppat.1003707
29. Gondek DC, Roan NR, Starnbach MN. T cell responses in the absence of IFN-
gamma exacerbate uterine infection with Chlamydia trachomatis. J Immunol
(2009) 183:1313–9. doi:10.4049/jimmunol.0900295
30. Su H, Feilzer K, Caldwell HD, Morrison RP. Chlamydia trachomatis genital
tract infection of antibody-deficient gene knockout mice. Infect Immun (1997)
65:1993–9.
31. McSorley SJ, Jenkins MK. Antibody is required for protection against viru-
lent but not attenuated Salmonella enterica serovar typhimurium. Infect Immun
(2000) 68:3344–8. doi:10.1128/IAI.68.6.3344-3348.2000
32. Mastroeni P, Simmons C, Fowler R, Hormaeche CE, Dougan G. Igh-6(-/-) (B-
cell-deficient) mice fail to mount solid acquired resistance to oral challenge
with virulent Salmonella enterica serovar typhimurium and show impaired
Th1 T-cell responses to Salmonella antigens. Infect Immun (2000) 68:46–53.
doi:10.1128/IAI.68.1.46-53.2000
33. Lee SJ,Dunmire S,McSorley SJ. MHC class-I-restricted CD8 T cells play a protec-
tive role during primary Salmonella infection. Immunol Lett (2012) 148:138–43.
doi:10.1016/j.imlet.2012.10.009
34. Moon JJ, McSorley SJ. Tracking the dynamics of Salmonella specific T cell
responses. Curr Top Microbiol Immunol (2009) 334:179–98. doi:10.1007/978-
3-540-93864-4_8
35. Williams DM, Grubbs BG, Pack E, Kelly K, Rank RG. Humoral and cellular
immunity in secondary infection due to murine Chlamydia trachomatis. Infect
Immun (1997) 65:2876–82.
36. Nanton MR, Way SS, Shlomchik MJ, McSorley SJ. Cutting edge: B cells are
essential for protective immunity against Salmonella independent of antibody
secretion. J Immunol (2012) 189:5503–7. doi:10.4049/jimmunol.1201413
37. Mastroeni P,Villarreal-Ramos B, Hormaeche CE. Adoptive transfer of immunity
to oral challenge with virulent Salmonella in innately susceptible BALB/c mice
requires both immune serum and T cells. Infect Immun (1993) 61:3981–4.
38. Morrison SG, Morrison RP. A predominant role for antibody in acquired immu-
nity to chlamydial genital tract reinfection. J Immunol (2005) 175:7536–42.
doi:10.4049/jimmunol.175.11.7536
39. Lo WF, Ong H, Metcalf ES, Soloski MJ. T cell responses to gram-negative intra-
cellular bacterial pathogens: a role for CD8+ T cells in immunity to Salmonella
infection and the involvement of MHC class Ib molecules. J Immunol (1999)
162:5398–406.
40. Jenkins MK, Khoruts A, Ingulli E, Mueller DL, McSorley SJ, Reinhardt RL, et al.
In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol (2001)
19:23–45. doi:10.1146/annurev.immunol.19.1.23
41. McSorley SJ, Asch S, Costalonga M, Rieinhardt RL, Jenkins MK. Tracking Sal-
monella-specific CD4 T cells in vivo reveals a local mucosal response to a dis-
seminated infection. Immunity (2002) 16:365–77. doi:10.1016/S1074-7613(02)
00289-3
42. Roan NR, Gierahn TM, Higgins DE, Starnbach MN. Monitoring the T cell
response to genital tract infection. Proc Natl Acad Sci U S A (2006) 103:12069–74.
doi:10.1073/pnas.0603866103
43. Lee SJ, McLachlan JB, Kurtz JR, Fan D, Winter SE, Baumler AJ, et al. Tempo-
ral expression of bacterial proteins instructs host CD4 T cell expansion and
Th17 development. PLoS Pathog (2012) 8:e1002499. doi:10.1371/journal.ppat.
1002499
44. Salazar-Gonzalez RM, Niess JH, Zammit DJ, Ravindran R, Srinivasan A,
Maxwell JR, et al. CCR6-mediated dendritic cell activation of pathogen-specific
T cells in Peyer’s patches. Immunity (2006) 24:623–32. doi:10.1016/j.immuni.
2006.02.015
45. Muller AJ, Filipe-Santos O, Eberl G, Aebischer T, Spath GF, Bousso P. CD4+ T
cells rely on a cytokine gradient to control intracellular pathogens beyond sites of
antigen presentation. Immunity (2012) 37:147–57. doi:10.1016/j.immuni.2012.
05.015
46. Bueno SM, Gonzalez PA, Schwebach JR, Kalergis AM. T cell immunity evasion
by virulent Salmonella enterica. Immunol Lett (2007) 111:14–20. doi:10.1016/j.
imlet.2007.05.003
47. Bedoui S, Kupz A, Wijburg OL, Walduck AK, Rescigno M, Strugnell RA. Dif-
ferent bacterial pathogens, different strategies, yet the aim is the same: eva-
sion of intestinal dendritic cell recognition. J Immunol (2010) 184:2237–42.
doi:10.4049/jimmunol.0902871
48. Horst D, Verweij MC, Davison AJ, Ressing ME, Wiertz EJ. Viral evasion of T cell
immunity: ancient mechanisms offering new applications. Curr Opin Immunol
(2011) 23:96–103. doi:10.1016/j.coi.2010.11.005
49. Lapaque N, Hutchinson JL, Jones DC, Meresse S, Holden DW, Trowsdale J, et al.
Salmonella regulates polyubiquitination and surface expression of MHC class
II antigens. Proc Natl Acad Sci U S A (2009) 106:14052–7. doi:10.1073/pnas.
0906735106
50. McLachlan JB, Catron DM, Moon JJ, Jenkins MK. Dendritic cell antigen pre-
sentation drives simultaneous cytokine production by effector and regulatory T
cells in inflamed skin. Immunity (2009) 30:277–88. doi:10.1016/j.immuni.2008.
11.013
51. Srivastava S, Ernst JD. Cutting edge: direct recognition of infected cells by CD4
T cells is required for control of intracellular Mycobacterium tuberculosis in vivo.
J Immunol (2013) 191:1016–20. doi:10.4049/jimmunol.1301236
52. Berg RE, Cordes CJ, Forman J. Contribution of CD8+ T cells to innate immu-
nity: IFN-gamma secretion induced by IL-12 and IL-18. Eur J Immunol (2002)
32:2807–16. doi:10.1002/1521-4141(2002010)32:10<2807::AID-IMMU2807>
3.0.CO;2-0
53. Freeman BE, Hammarlund E, Raue HP, Slifka MK. Regulation of innate CD8+
T-cell activation mediated by cytokines. Proc Natl Acad Sci U S A (2012)
109:9971–6. doi:10.1073/pnas.1203543109
54. Lertmemongkolchai G, Cai G, Hunter CA, Bancroft GJ. Bystander activation of
CD8+ T cells contributes to the rapid production of IFN-gamma in response to
bacterial pathogens. J Immunol (2001) 166:1097–105. doi:10.4049/jimmunol.
166.2.1097
55. Srinivasan A,Salazar-Gonzalez RM,Jarcho M,Sandau MM,Lefrancois L,McSor-
ley SJ. Innate immune activation of CD4 T cells in Salmonella-infected mice is
www.frontiersin.org July 2014 | Volume 5 | Article 319 | 5
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
McSorley Immune response to intracellular bacterial infections
dependent on IL-18. J Immunol (2007) 178:6342–9. doi:10.4049/jimmunol.178.
10.6342
56. Srinivasan A, McSorley SJ. Pivotal advance: exposure to LPS suppresses CD4+
T cell cytokine production in Salmonella-infected mice and exacerbates murine
typhoid. J Leukoc Biol (2007) 81:403–11. doi:10.1189/jlb.0306194
57. O’Donnell H, Pham OH, Li LX, Atif SM, Lee SJ, Ravesloot MM, et al. Toll-like
receptor and inflammasome signals converge to amplify the innate bactericidal
capacity of T helper 1 cells. Immunity (2014) 40:213–24. doi:10.1016/j.immuni.
2013.12.013
58. Broz P, Monack DM. Molecular mechanisms of inflammasome activation dur-
ing microbial infections. Immunol Rev (2011) 243:174–90. doi:10.1111/j.1600-
065X.2011.01041.x
59. Kupz A, Guarda G, Gebhardt T, Sander LE, Short KR, Diavatopoulos DA,
et al. NLRC4 inflammasomes in dendritic cells regulate noncognate effector
function by memory CD8 T cells. Nat Immunol (2012) 13:162–9. doi:10.1038/
ni.2195
60. Beadling C, Slifka MK. How do viral infections predispose patients to bacter-
ial infections? Curr Opin Infect Dis (2004) 17:185–91. doi:10.1097/00001432-
200406000-00003
61. Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS,
et al. Herpesvirus latency confers symbiotic protection from bacterial infection.
Nature (2007) 447:326–9. doi:10.1038/nature05762
Conflict of Interest Statement: The author declares that the research was conducted
in the absence of any commercial or financial relationships that could be construed
as a potential conflict of interest.
Received: 21 May 2014; accepted: 24 June 2014; published online: 09 July 2014.
Citation: McSorley SJ (2014) The role of non-cognate T cell stimulation during intra-
cellular bacterial infection. Front. Immunol. 5:319. doi: 10.3389/fimmu.2014.00319
This article was submitted to Immunological Memory, a section of the journal Frontiers
in Immunology.
Copyright © 2014 McSorley. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or repro-
duction in other forums is permitted, provided the original author(s) or licensor are
credited and that the original publication in this journal is cited, in accordance with
accepted academic practice. No use, distribution or reproduction is permitted which
does not comply with these terms.
Frontiers in Immunology | Immunological Memory July 2014 | Volume 5 | Article 319 | 6
